Cover Image
市場調查報告書

Indian Immunologicals Limited的產品平台分析

Indian Immunologicals Limited - Product Pipeline Review - 2016

出版商 Global Markets Direct 商品編碼 317362
出版日期 內容資訊 英文 29 Pages
訂單完成後即時交付
價格
Back to Top
Indian Immunologicals Limited的產品平台分析 Indian Immunologicals Limited - Product Pipeline Review - 2016
出版日期: 2016年02月29日 內容資訊: 英文 29 Pages
簡介

Indian Immunologicals Limited是總公司位於印度的製藥公司,從事兒童用疫苗及人用狂犬病疫苗的研究開發,製造,出口。同時也擁有動物健康、人類健康,提升家畜生產率的服務部門,正在發展國際性商務。

本報告提供Indian Immunologicals Limited的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Indian Immunologicals Limited的基本資料

  • Indian Immunologicals Limited概要
  • 主要資訊
  • 企業資料

Indian Immunologicals Limited:R&D概要

  • 主要的治療範圍

Indian Immunologicals Limited:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Indian Immunologicals Limited:開發中產品概況

  • 臨床階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 臨床試驗前階段的產品/聯合治療模式
  • 開發階段不明的產品
    • 開發階段不明的產品/聯合治療模式

Indian Immunologicals Limited:藥物簡介

  • chikungunya vaccine
  • DPT-H-HiB Vaccine
  • haemophilus influenzae vaccine type B
  • human papilloma virus vaccine types 16 and 18
  • alphavirus vaccine
  • flavivirus vaccine
  • Japanese encephalitis vaccine
  • picornavirus vaccine
  • vaccine for cervical cancer
  • Vaccine for Undisclosed Indication

Indian Immunologicals Limited:開發平台分析

  • 各給藥途徑
  • 各分子類型

Indian Immunologicals Limited:總公司和子公司的所在地

  • 總公司
  • 分公司及子公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07972CDB

Summary

Global Markets Direct's, 'Indian Immunologicals Limited - Product Pipeline Review - 2016', provides an overview of the Indian Immunologicals Limited's pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Indian Immunologicals Limited, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Indian Immunologicals Limited
  • The report provides overview of Indian Immunologicals Limited including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Indian Immunologicals Limited's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Indian Immunologicals Limited's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

  • Evaluate Indian Immunologicals Limited's strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Indian Immunologicals Limited
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Indian Immunologicals Limited's pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Indian Immunologicals Limited Snapshot
    • Indian Immunologicals Limited Overview
    • Key Information
    • Key Facts
  • Indian Immunologicals Limited - Research and Development Overview
    • Key Therapeutic Areas
  • Indian Immunologicals Limited - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
  • Indian Immunologicals Limited - Pipeline Products Glance
    • Indian Immunologicals Limited - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Indian Immunologicals Limited - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
    • Indian Immunologicals Limited - Unknown Stage Pipeline Products
      • Unknown Products/Combination Treatment Modalities
  • Indian Immunologicals Limited - Drug Profiles
    • (diphtheria + Haemophilus influenza [serotype B] + hepatitis B + pertussis (wholl cell) + tetanus) (pentavalent) vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • chikungunya vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • human papillomavirus [serotypes 16, 18] vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Japanese encephalitis vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Alphavirus vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • flavivirus vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • picornavirus vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Vaccine for Undisclosed Indication
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Indian Immunologicals Limited - Pipeline Analysis
    • Indian Immunologicals Limited - Pipeline Products by Target
    • Indian Immunologicals Limited - Pipeline Products by Route of Administration
    • Indian Immunologicals Limited - Pipeline Products by Molecule Type
  • Indian Immunologicals Limited - Recent Pipeline Updates
  • Indian Immunologicals Limited - Dormant Projects
  • Indian Immunologicals Limited - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Indian Immunologicals Limited, Key Information
  • Indian Immunologicals Limited, Key Facts
  • Indian Immunologicals Limited - Pipeline by Indication, 2016
  • Indian Immunologicals Limited - Pipeline by Stage of Development, 2016
  • Indian Immunologicals Limited - Monotherapy Products in Pipeline, 2016
  • Indian Immunologicals Limited - Combination Treatment Modalities in Pipeline, 2016
  • Indian Immunologicals Limited - Phase I, 2016
  • Indian Immunologicals Limited - Preclinical, 2016
  • Indian Immunologicals Limited - Unknown, 2016
  • Indian Immunologicals Limited - Pipeline by Target, 2016
  • Indian Immunologicals Limited - Pipeline by Route of Administration, 2016
  • Indian Immunologicals Limited - Pipeline by Molecule Type, 2016
  • Indian Immunologicals Limited - Recent Pipeline Updates, 2016
  • Indian Immunologicals Limited - Dormant Developmental Projects,2016
  • Indian Immunologicals Limited, Other Locations

List of Figures

  • Indian Immunologicals Limited - Pipeline by Top 10 Indication, 2016
  • Indian Immunologicals Limited - Pipeline by Stage of Development, 2016
  • Indian Immunologicals Limited - Monotherapy Products in Pipeline, 2016
  • Indian Immunologicals Limited - Pipeline by Route of Administration, 2016
  • Indian Immunologicals Limited - Pipeline by Molecule Type, 2016
Back to Top